Filing Details

Accession Number:
0000950170-25-085490
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-06-12 16:37:21
Reporting Period:
2025-06-10
Filing Date:
2025-06-12
Accepted Time:
2025-06-12 16:37:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1815776 Lenz Therapeutics Inc. LENZ () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1687880 Versant Venture Capital Vi, L.p. One Sansome Street, Suite 1650
San Francisco CA 94104
No No No No
1750266 Versant Venture Capital Vii, L.p. One Sansome Street, Suite 1650
San Francisco CA 94104
No No No No
1777652 Versant Ventures Vi Gp-Gp, Llc One Sansome Street, Suite 1650
San Francisco CA 94104
No No No No
1777654 Versant Ventures Vi Gp, L.p. One Sansome Street, Suite 1650
San Francisco CA 94104
No No No No
1777655 Versant Ventures Vii Gp, L.p. One Sansome Street, Suite 1650
San Francisco CA 94104
No No No No
1777656 Versant Ventures Vii Gp-Gp, Llc One Sansome Street, Suite 1650
San Francisco CA 94104
No No No No
1832235 Versant Vantage Ii, L.p. One Sansome Street, Suite 1650
San Francisco CA 94104
No No No No
1839789 Versant Vantage Ii Gp-Gp, Llc One Sansome Street, Suite 1650
San Francisco CA 94104
No No No No
1839790 Versant Vantage Ii Gp, L.p. One Sansome Street, Suite 1650
San Francisco CA 94104
No No No No
Transaction Summary
Sold: 350,000 shares Avg. Price: $29.00 Total Value: $10,150,000.00
Number of Shares After Transactions: 1,248,789 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-06-10 350,000 $29.00 1,248,789 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,101,199 Direct
Common Stock 842,162 Indirect See footnote
Footnotes
  1. These shares are held by Versant Venture Capital VII, L.P. ("VVC VII"). Versant Ventures VII GP-GP, LLC ("VV VII GP") is the sole general partner of Versant Ventures VII GP, L.P. ("VV VII") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.
  2. These shares are held by Versant Venture Capital VI, L.P. ("VVC VI"). Versant Ventures VI GP-GP, LLC ("VV VI GP") is the sole general partner of Versant Ventures VI GP, L.P. ("VV VI") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.
  3. These shares are held by Versant Vantage II, L.P. ("VV II"). Versant Vantage II GP-GP, LLC ("VV II GP-GP") is the sole general partner of Versant Vantage II GP, L.P. ("VV II GP") and VV II GP is the sole general partner of VV II. Each of VV II GP-GP and VV II GP may be deemed to share voting, investment and dispositive power over the shares held by VV II and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.